For the first time, researchers have determined that a molecule called VPS35 can clear tau proteins, a hallmark of Alzheimer’s disease, in the brain. That’s according to a new study published in the journal Molecular Psychiatry.
Think of the molecule VPS35 as a quality control worker in the brain – it picks through and removes defective proteins from neurons. This VPS35 system protects the brain by getting rid of the gunk that would otherwise clog up the brain’s inner workings.
In people with Alzheimer’s disease (as well as other neurodegenerative conditions like Parkinson’s), VPS35 doesn’t work in the way that it should. It’s not as good at detecting and clearing those defective proteins.
One such protein, tau, amasses in the brain and causes damage in Alzheimer’s patients. Until now, researchers did not understand the relationship between tau and the VPS35 system, and whether VPS35 could impact tau accumulation in the brain.
“We asked specifically whether the VPS35 system is important for clearing defective tau proteins,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine (LKSOM).
To figure this out, Praticò’s team looked at brain tissue from patients with progressive supra-nuclear palsy (PSP) or Picks’ disease. In PSP and Picks’ disease, tau is the only protein to form deposits in the brain, unlike Alzheimer’s disease, where both tau and beta-amyloid accumulate.
VPS35 Levels Directly Impact Tau Protein in Brain and Memory Issues
The researchers found that VPS35 levels in PSP and Picks’ patients were 50 percent lower than in healthy control subjects. When the scientists manipulated VPS35 levels in the lab, they discovered that they could control tau accumulation in tau-affected cells.
When they carried out further experiments in mice, lowering their VPS35 levels resulted in worsened memory, motor function and learning issues. It also significantly damaged neuron communication in the brain synapses. (This is where neurons meet and exchange signals, explained Praticò.)
According to Praticò, his next avenue of investigation will be whether they can use a drug to put VPS35 back to work to help clear tau tangles.
Past research has suggested that clearing tau tangles could help reverse or stop the progression of Alzheimer’s disease.
Read Next: Tau Protein and Alzheimer’s: Does This Protein Hold the Key to a Cure?
11 thoughts on “Researchers Discover Brain Molecule, VPS35, Can Clear Alzheimer’s Tau Tangles”
Will you be doing trials and how can someone be in that trial? My sister has PSP and this sounds very hopeful!
VPS35…Sorting protein in neurons defends against neurodegenerative disease.
is VPS35 in ant foods? Is it available anywhere?
My husband was just diagnosed with Alzheimers. Can he be involved?
I have MCI executive function. I believe the Tau proteins is the problem and if you need volunteers for your test I would be interested.
My husband has MCI and is willing to do a trial
I am 54 years old and am in very good health. I have been diagnosed with Early Onset Alzheimers. I too am feeling hopeful. Just this morning, I said to my husband of 30 years Wouldn’t it be amazing to find the cure for Alzheimer’s before I die. Praying for a cure…from our scientists and researches.
I should have added that my prognosis is 8 to 10 years and I have no limitations yet.
How do we access this protein? Is it in certain foods?
I am 59 & and in excellent condition (my doctor suggest i run 30 kilometer each week to stay strong. So relieved that you are solving this important puzzle. Please Keep Going!
My son has autism and lab results discovered elevated tau. Would be interested in participating in trials. Please reach out at your earliest convenience.
My husband could use a trial he has been diagnosed with Alzheimer’s disease since 2020.